Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1/3
Experience of MTZ Clinical Research in Bioequivalence studies
Lp. Therapeutic /Chemical subgroup Chemical substance Population
Alimentary tract and metabolism
1 Drugs used in diabetes Glimepiride Healthy subjects
2 Lipid modifying agents Lovastatin Healthy subjects
3 Lipid modifying agents Rosuvastatin Healthy subjects
4 Lipid modifying agents Rosuvastatin Healthy subjects
5 Lipid modifying agents Simvastatin Healthy subjects
Antiinfectives for systemic use
6 Antibacterials for systemic use Azithromycin Healthy subjects
7 Antibacterials for systemic use Azithromycin Healthy subjects
8 Antibacterials for systemic use Azithromycin Healthy subjects
9 Antivirals for systemic use Oseltamivir Healthy subjects
10 Antivirals for systemic use Aciclovir Healthy subjects
Antineoplastic and immunomodulating agents
11 Antineoplastic agents Capecitabine Healthy subjects
12 Antineoplastic agents Capecitabine
Metastatic Solid Tumors
13 Antineoplastic agents Capecitabine
Metastatic Solid
Tumors
14 Antineoplastic agents Capecitabine Healthy subjects
15 Antineoplastic agents Capecitabine Healthy subjects
16
Antineoplastic agents
Doxorubicin Hydrochloride
Liposome
Advanced Carcinoma
of the Ovary
17 Taxane Paclitaxel
Metastatic breast cancer
Blood and blood forming organs
18 Antithrombotic agents Acetylsalicylic Acid Healthy subjects
Cardiovascular system
19 Agents acting on the renin-angiotensin system Lisinopril Healthy subjects
20 Agents acting on the renin-angiotensin system Lisinopril Healthy subjects
21 Agents acting on the renin-angiotensin system Lisinopril Healthy subjects
22 Calcium channel blockers Nitrendypine Healthy subjects
23
Calcium channel blockers
Nicardipine
hydrochloride Healthy subjects
24 Cardiac therapy
Isosorbide-5-mononitrate Healthy subjects
25 Cardiac therapy
Isosorbide-5-mononitrate Healthy subjects
26
Cardiac therapy
Isosorbide-5-
mononitrate Healthy subjects
27 Diuretics Indapamide Healthy subjects
28 Diuretics Indapamide Healthy subjects
29 Lipid modifying agents Simvastatin Healthy subjects
30 Vasoprotectives Calcium dobesilate Healthy subjects
Experience of MTZ Clinical Research Early Clinical Development
2/3
Date of issue: May 2019
Lp. Therapeutic /Chemical subgroup Chemical substance Population
Dermatologicals
31 Antipsoriatics Tacalcitol Plaque Psoriasis
32 Antipsoriatics Tacalcitol Plaque Psoriasis
33 Corticosteroids Mometasone furoate Healthy subjects
34 Corticosteroids Mometasone furoate Healthy subjects
35 Corticosteroids Mometasone furoate Healthy subjects
36 Corticosteroids Mometasone furoate Healthy subjects
37
Corticosteroids
Betamethasone
dipropionate
Healthy subjects
38
Corticosteroids
Betamethasone dipropionate and
salicylic acid
Healthy subjects
39
Corticosteroids
Betamethasone dipropionate and
salicylic acid
Healthy subjects
40
Corticosteroids
Betamethasone
dipropionate and
gentamicin sulfate
Healthy subjects
41
Corticosteroids
Betamethasone
dipropionate and
gentamicin sulfate
Healthy subjects
42 Flavonoid Genistein Healthy subjects
Genito-urinary system and sex hormones
43 Sex hormones and modulators of the genital system Megestrol Healthy subjects
44 Sex hormones and modulators of the genital
system Megestrol Healthy subjects
Musculo-skeletal system
45 Antiinflammatory and antirheumatic products Ibuprofen Healthy subjects
46 Antiinflammatory and antirheumatic products Ibuprofen Healthy subjects
47 Antiinflammatory and antirheumatic products Ibuprofen Healthy subjects
48 Anti-inflammatory and antirheumatic products Ibuprofen Healthy subjects
49 Antiinflammatory and antirheumatic products Naproxen Healthy subjects
50 Drugs for treatment of bone diseases Alendronic acid Healthy subjects
51 Drugs for treatment of bone diseases Risedronic acid Healthy subjects
52 Muscle relaxants Thiocolchicoside Healthy subjects
Nervous system
53 Antiepileptics Lamotrigine Healthy subjects
54 Antiepileptics Pregabalin Healthy subjects
55 Antiepileptics Topiramate Healthy subjects
56 Antiepileptics Topiramate Healthy subjects
57
Antivertigo preparations
Cinnarazinum &
Dimenhydrinatum Healthy subjects
58 Other nervous system drugs Betahistine Healthy subjects
59 Psychoanaleptics Amitriptyline Healthy subjects
60 Psychoanaleptics Amitriptyline Healthy subjects
61 Psychoanaleptics Aniracetam Healthy subjects
62 Psychoanaleptics Memantine Healthy subjects
63 Psychoanaleptics Mirtazapine Healthy subjects
64 Psychoanaleptics Rasagiline Healthy subjects
Experience of MTZ Clinical Research Early Clinical Development
3/3
Date of issue: May 2019
Lp. Therapeutic /Chemical subgroup Chemical substance Population
65 Psychoanaleptics Trazodone Healthy subjects
66 Psycholeptics Olanzapine Healthy subjects
Respiratory system
67 Antihistamines Clemastine Healthy subjects
68 Antihistamines Levocetirizine Healthy subjects
69 Antihistamines Loratadine Healthy subjects
70 Drugs for obstructive airway diseases
Fluticasone propionate / salmeterol Healthy subjects
71 Drugs for obstructive airway diseases Mometasone furoate Healthy subjects
72 Drugs for obstructive airway diseases Mometasone furoate Healthy subjects
73 Nasal preparations Fluticasone furoate Healthy subjects
Various
74 Antiinflammatory / Sympathomimetics
Ibuprofen /
Pseudoephedrine
Healthy subjects
75 Antiinflammatory / Sympathomimetics
Ibuprofen / Pseudoephedrine
Healthy subjects